Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cytokeratin 13 antibody

Cited in 5+ publications. The Mouse Monoclonal anti-Cytokeratin 13 antibody (Clone Ks13-1) (ABIN335313) specifically detects Cytokeratin 13 in WB, IHC (p) and IHC (fro). The antibody is reactive with Various Species samples.
Catalog No. ABIN335313
-20% for 20 Years of ABO
$446.58
$558.22
save $111.64 (-20 %)
Plus shipping costs $50.00
1 mL
Shipping to: United States
Delivery in 1 to 3 Business Days

Quick Overview for Cytokeratin 13 antibody (ABIN335313)

Target

See all Cytokeratin 13 (KRT13) Antibodies
Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Reactivity

  • 133
  • 35
  • 22
  • 11
  • 8
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Various Species

Host

  • 83
  • 52
  • 1
  • 1
Mouse

Clonality

  • 79
  • 58
Monoclonal

Conjugate

  • 84
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Cytokeratin 13 antibody is un-conjugated

Application

  • 82
  • 69
  • 40
  • 24
  • 22
  • 22
  • 16
  • 13
  • 10
  • 8
  • 7
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone

Ks13-1
  • Purpose

    Mouse anti Cytokeratin 13

    Specificity

    Ks13.1 reacts exclusively with Cytokeratin 13 which is present in non-cornified squamous epithelia, except cornea, and transitional epithelial regions, with the exception of basal cell layers of some stRatified epithelia. As a result the antibody also reacts with neoplasms derived from these epithelia.

    Characteristics

    Cytokeratins are a subfamily of intermediate filament proteins and are characterized by a remarkable biochemical diversity, represented in Human epithelial tissues by at least 20 different polypeptides. They range in molecular weight between 40 kDa and 68 kDa and isoelectric pH between 4.9 - 7.8. The individual Human Cytokeratins are numbered 1 to 20. The various epithelia in the Human body usually express Cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of matuRation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The Cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays.

    Purification

    culture supernatant

    Immunogen

    Ks13.1 is a Mouse monoclonal IgG1 antibody derived by fusion of SP2/0 Mouse myeloma cells with spleen cells from a BALB/c Mouse immunized with a Cytokeratin preparation extracted from Human esophagus.

    Isotype

    IgG1
  • Application Notes

    Ks13.1 is suitable for immunoblotting and immunohistochemistry on frozen tissues and paraffin embedded tissue after protease pretreatment. Optimal antibody dilution should be determined by titration.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Each vial contains 1 mL of culture supernatant of monoclonal antibody containing 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    The antibody is shipped at ambient temperature and may be stored at +4°C. For prolonged storage prepare appropriate aliquots and store at or below -20°C. Prior to use, an aliquot is thawed slowly in the dark at ambient temperature, spun down again and used to prepare working dilutions by adding sterile phosphate buffered saline (PBS, pH 7.2). Repeated thawing and freezing should be avoided. Working dilutions should be stored at +4°C, not refrozen, and preferably used the same day. If a slight precipitation occurs upon storage, this should be removed by centrifugation. It will not affect the performance or the concentration of the product.
  • Demirkesen, Hoede, Moll: "Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins." in: Journal of cutaneous pathology, Vol. 22, Issue 6, pp. 518-35, (1996) (PubMed).

    Dallenbach-Hellweg, Lang: "Immunohistochemical studies on uterine tumors. I. Invasive squamous cell carcinomas of the cervix and their precursors." in: Pathology, research and practice, Vol. 187, Issue 1, pp. 36-43, (1991) (PubMed).

    Moll, Achtstätter, Becht, Balcarova-Ständer, Ittensohn, Franke: "Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines." in: The American journal of pathology, Vol. 132, Issue 1, pp. 123-44, (1988) (PubMed).

    Dockhorn-Dworniczak, Franke, Schröder, Czernobilsky, Gould, Böcker: "Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas." in: Differentiation; research in biological diversity, Vol. 35, Issue 1, pp. 53-71, (1988) (PubMed).

    Moll, Franke, Schiller, Geiger, Krepler: "The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells." in: Cell, Vol. 31, Issue 1, pp. 11-24, (1983) (PubMed).

  • Target

    Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

    Alternative Name

    Cytokeratin 13 / Keratin K13

    UniProt

    P13646
You are here:
Chat with us!